COMUNICATO STAMPA SPONSORIZZATO – Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

(Immediapress) – FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ — Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ AD 5-plex Assay. This innovative solution enables simultaneous quantitative measurement of five critical blood-based biomarkers relevant […] L'articolo COMUNICATO STAMPA SPONSORIZZATO – Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research proviene da La Ragione.

CONTINUA A LEGGERE